Results 181 to 190 of about 8,535,407 (297)
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Effect of a salutogenic program on depression, self-harming behaviour and sense of coherence among elderly residents of an old age home in Odisha. [PDF]
Sahoo I, Pahantasingh S, Moharana S.
europepmc +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Sense of Belongingness among Anesthesiology Residents: Adapting a Validated Tool to Establish Benchmarks and Identify Outliers. [PDF]
Cormier NR +4 more
europepmc +1 more source
Making sense of oxygen sensing
Peter J Ratcliffe, Thomas P Keeley
openaire +3 more sources
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Correction: Research on the influence of psychological fatigue of short track speed skaters on sports motivation. [PDF]
Frontiers Production Office.
europepmc +1 more source

